Wnt binds frizzled, promoting the stabilization, nuclear translocation and transcriptional activity of β -catenin through its interaction with T-cell factor (TCF) family transcription factors. Recently, R-spondin (Rspo) growth factors were found to amplify Wnt signalling by engaging leucine-rich repeat-containing G-protein-coupled receptor (Lgr)4, Lgr5 and Lgr6 (ref. 6). Lgr5 marks stem cells in multiple epithelial tissues and in intestinal adenomas 3,[6][7][8] . Stem-like cells have recently been described in autochthonous mouse tumour models 7,9,10 and in tumour transplants [11][12][13] + cells ten days after plating. Rspo2-a, Rspo3-a and Lgr5-a refer to cells expressing CRISPR-activator (SAM) components driving expression of the indicated gene. n = 8 wells per condition. e, Wnt pathway activity measured by the Topflash assay in cultured KP LUAD cells stably expressing shRNAs targeting Lgr4, Lgr5, both Lgr4 and Lgr5 or a vector control. n = 3 technical replicates per condition, experiment was repeated four times. Data are mean ± s.d.; two-way ANOVA (b, d, e) or Student's t-test (c); * P < 0.05; * * P < 0.01; * * * P < 0.001 compared to control, except in d, where the LGK974 group is compared to the same CRISPR-activator line, and in e where the comparison is to Rspo1 stimulation.
Stem cells are defined by their capacity to self-renew while also producing differentiated cells. The decision to divide or differentiate is primarily controlled by extrinsic signalling factors, which, together with the cells that produce them, form a niche with a local range of action capable of supporting a limited number of stem cells. Among the niche signals that promote stem-cell phenotypes, secreted Wnt proteins are notable owing to their function in multiple epithelial stem cell compartments 3 . Wnt growth factors are palmitoylated in cells that produce them by the membrane-bound O-acyltransferase porcupine (encoded by Porcn in mice) 3 . This posttranslational modification is essential for Wnt secretion and binding to frizzled family receptors 3 . Wnt binds frizzled, promoting the stabilization, nuclear translocation and transcriptional activity of β -catenin through its interaction with T-cell factor (TCF) family transcription factors. Recently, R-spondin (Rspo) growth factors were found to amplify Wnt signalling by engaging leucine-rich repeat-containing G-protein-coupled receptor (Lgr)4, Lgr5 and Lgr6 (ref. 6). Lgr5 marks stem cells in multiple epithelial tissues and in intestinal adenomas 3, [6] [7] [8] . Stem-like cells have recently been described in autochthonous mouse tumour models 7,9,10 and in tumour transplants [11] [12] [13] , but evidence for the existence of stem-like cells and particularly their niche in advanced solid tumours in situ has been limited 14 . Lung adenocarcinoma (LUAD) is a leading cause of death globally. Tumours driven by oncogenic KRAS account for approximately 30% of LUAD and effective chemotherapies against these tumours are lacking 15 . Wnt signalling is essential for the initiation and maintenance of Braf-driven lung adenomas in mice 16 , and forced activation of the pathway promotes progression of Kras or Braf mutant lung tumours 16, 17 . LUAD in humans, in particular tumour metastasis, is frequently associated with increased expression of Wnt-pathwayactivating genes and downregulation of negative regulators of this pathway 18, 19 . 
d, Quantification of tumour spheroids containing EdU
+ cells ten days after plating. Rspo2-a, Rspo3-a and Lgr5-a refer to cells expressing CRISPR-activator (SAM) components driving expression of the indicated gene. n = 8 wells per condition. e, Wnt pathway activity measured by the Topflash assay in cultured KP LUAD cells stably expressing shRNAs targeting Lgr4, Lgr5, both Lgr4 and Lgr5 or a vector control. n = 3 technical replicates per condition, experiment was repeated four times. Data are mean ± s.d.; two-way ANOVA (b, d, e) or Student's t-test (c); * P < 0.05; * * P < 0.01; * * * P < 0.001 compared to control, except in d, where the LGK974 group is compared to the same CRISPR-activator line, and in e where the comparison is to Rspo1 stimulation. We isolated tdTomato + primary cancer cells from autochthonous Kras G12D/+ ;Trp53 Δ/Δ ;Rosa26 tdTomato/+ (KPT) mouse LUAD, and established low-density three-dimensional (3D) organotypic tumour spheroid cultures. 2.7% (± 0.5% (mean ± s.d.)) of the cells gave rise to persistently proliferating spheroids (Fig. 1a, b) , suggesting that cells capable of self-renewal comprise a small minority of the tumour. Recombinant Wnt3a, Rspo1 or their combination increased the absolute number and ratio of primary mouse KPT LUAD spheroids that contained proliferating cells, and promoted overall cell proliferation (Fig. 1a, b and Extended Data Fig. 1a, b) ) suppressed proliferative capacity of primary LUAD cells in 3D spheroids (Fig. 1a, b and Extended Data Fig. 1a-f) . Tumour formation by primary LUAD cells was markedly decreased upon orthotopic transplantation (genetically engineered mouse model-derived allograft, GEMM-DA) into recipient mice that were treated with LGK974 compared to control (Fig. 1c and Extended Data Fig. 1g ). Collectively, these data indicate that KP LUAD cells display heterogeneity in their proliferative potential, which is maintained by Wnt signals produced by cancer cells.
Rspo1 alone was most potent in stimulating proliferation and expansion of KPT LUAD spheroids (Fig. 1a, b and Extended Data Fig. 1a ), even though, as expected, the combination of recombinant Rspo1 and Wnt3a was most potent in activating the Wnt pathway (Extended Data  Fig. 1e , h and Supplementary Information). We next used the CRISPRCas9-based synergistic activation mediator (SAM) system 21 to robustly drive expression of Rspo2, Rspo3 or Lgr5 in KP LUAD cells (Extended Data Fig. 1i-l) . This increased their proliferation and induced Wnt target genes in 3D spheroid culture and both of these effects were suppressed by LGK974 ( Fig. 1d and Extended Data Fig. 1m, n) . Knockdown of both Lgr4 and Lgr5 was required to fully suppress R-spondin-driven Wnt pathway activation ( Fig. 1e and Extended Data Fig. 2a-g ), indicating that both Lgr4 and Lgr5 are R-spondin receptors in the KP LUAD model.
We next assessed whether the Wnt pathway is activated in autochthonous KP LUAD tumours in vivo. Using a luciferase or GFP-reporter gene driven by a synthetic β -catenin-sensitive 7TCF promoter, we observed Wnt-pathway activation in a subpopulation of cancer cells, particularly in large autochthonous KP tumours (Fig. 2a, b) . In subcutaneous transplants of KP tumour lines, 7TCF promoter activity was suppressed by treatment with LGK974 (Extended Data Fig. 3a-c) . Notably, we observed nuclear localization of β -catenin, a hallmark of activation of Wnt signalling, in a subpopulation of cancer cells, only in tumours that had progressed from adenoma to adenocarcinoma (Fig. 2c, d and Extended Data Fig. 3d) .
We next performed porcupine immunostaining in tumour sections to identify cells that were able to produce Wnt in the LUAD tumours. Porcupine localized to cancer cells in close proximity to cells with nuclear β -catenin or expression of the Wnt target gene Axin2 in autochthonous KP LUAD, although rare porcupine + macrophages were also detected, predominantly in peritumoural areas ( Fig. 2c and Extended Data Fig. 3e-i) . Furthermore, Porcn gene expression was significantly higher in adenocarcinomas compared to adenomas (Fig. 2e) . Notably, we detected similar porcupine-or nuclear β -catenin-positive subpopulations and induction of PORCN expression in human LUAD ( Fig. 2f and Extended Data Fig. 3j, k) . These findings indicate that the Wnt pathway is activated in a subpopulation of lung adenocarcinoma cells in close proximity to porcupine + cells that are able to provide the Wnt signal. Porcupine localized to bronchiolar epithelium in the normal lung and was restricted to sites of high Wnt signalling and stem cell activity in the intestine and liver 3 (Extended Data Fig. 4a-e) , suggesting that porcupine is specifically expressed in Wnt-producing cells in normal stem cell niches.
To test the functional requirement for porcupine expression in LUAD cells in vivo, we used CRISPR-Cas9 to inactivate Porcn specifically in Fig. 2g and Extended Data Fig. 5a ). However, targeting Porcn reduced tumour burden and resulted in a shift to lower grade tumours at 20 weeks compared to control (Fig. 2g, h ). Of note, of the 12 tumours that were graded as adenocarcinomas, 10 predominantly contained wild-type Porcn alleles or small non-frameshift mutations(Extended Data Fig. 5b, c) . In 2 out of 12 of these tumours, in which substantial allelic fractions of frameshift mutations were detected, the tumours still maintained residual porcupine immunopositivity (data not shown). These data suggest that only tumours with at least a fraction of cells retaining functional Porcn were capable of progressing beyond adenomas.
Lgr5 is a Wnt target gene functionally involved in amplification of Wnt signalling and stem cell maintenance in multiple tissues 3, 6 . When compared to adenomas, KP adenocarcinomas had an increased level of Lgr5 transcripts, which localized to a subpopulation of adenocarcinoma cells (Extended Data Fig. 6a, b) . Lgr4 expression in KP LUAD tumours was more widespread compared to Lgr5, much like in normal intestinal crypts 6 , but was enriched in the Lgr5 + cells (Extended Data Fig. 6b-d) . Furthermore, in GEMM-DAs established from KP LUAD tumours containing an Lgr5 GFP-CreER/+ reporter allele, the Lgr5 + cells were localized in close proximity to porcupine + cancer cells (Fig. 3a) . Sorted primary Lgr5
+ KP LUAD cells were more efficient at forming persistently proliferating spheroids in vitro and orthotopic KP LUAD GEMM-DA tumours in vivo than the Lgr5 − cells (Fig. 3b and Extended Data Fig. 6e-g ), suggesting that these cells have a high proliferative potential.
To investigate whether the Lgr5 + cells also display stem-like properties in situ in established tumours, we established subcutaneous KP LUAD GEMM-DAs containing Lgr5
CreER and Rosa26 mTmG alleles, which allowed inducible labelling of the Lgr5 + lineage in established tumours with membrane-associated GFP (mGFP) using tamoxifen. Single mGFP + cells were found two days after the tamoxifen pulse in porcupine + niches, whereas significant expansion of the Lgr5 + clones was observed at 14 days after tamoxifen administration (Fig. 3c) . The absolute number of clones did not change significantly over time (Extended Data Fig. 6h) . Notably, the Lgr5 + cells gave rise to porcupine + cells during the 14-day chase (Fig. 3c) , indicating that the Lgr5 LSL-Cas9-2a-GFP/+ mice infected with the indicated lentiviral vectors. hU6, human U6 promoter; sU6, synthetic U6 promoter; EFS, minimal E1α promoter. n = 6 (sgTom), n = 7 (sgLgr4 + sgLgr5). e, mRNA ISH for the indicated transcripts (purple) in consecutive sections of a similar region of a KP lung adenocarcinoma. Scale bars, 2 mm (d) and 100 μ m (b, c, e). Data are mean ± s.d.; * P < 0.05, * * P < 0.01; Student's two-sided t-test (a-d). In line with these findings, we detected porcupine + cells in close proximity to a subpopulation of Lgr5 + cells, which had increased proliferative potential in a PDAC GEMM (Extended Data Fig. 7c-f ). Furthermore, Lgr5
+ stemlike cells have been described in intestinal adenomas 7 . We detected porcupine + cells in close proximity to the Lgr5
GFP-CreER/+ mouse intestinal adenomas and porcupine expression in human colorectal carcinomas (Extended Data Fig. 7g, h ). These results suggest that paracrine Wnt signals may maintain subpopulations of cancer cells in a stem-like state in other epithelial cancers.
To explore the relevance of increased Wnt signalling in human nonsmall cell lung cancer, we examined gene expression patterns in The Cancer Genome Atlas (TCGA) LUAD dataset. A ligand-stimulated Wnt gene expression signature 22 correlated with poor survival and higher tumour grade, and was independently prognostic in human LUAD, but not in squamous cell lung cancer (Extended Data Fig. 8a -c and Supplementary Table 1) . We then extended this analysis to 34 additional human cancers within the TCGA dataset, and found similar correlations in PDAC and in mesothelioma (Extended Data Fig. 8d , e).
Given that KP LUAD cells respond to R-spondins through Lgr4 and Lgr5, we investigated the requirement for these genes in the KP model. CRISPR-Cas9-based combined inactivation of Lgr4 and Lgr5 in the KP model led to reduced lung tumour burden and prevented progression of adenomas to adenocarcinomas (Fig. 3d) , similar to what was observed when targeting Porcn (Fig. 2g) . Tumours that progressed into adenocarcinomas predominantly contained wild-type alleles or small non-frameshift mutations in Lgr4 and Lgr5 (Extended Data Fig. 8f-h ). These data are consistent with a key role for Lgr4 and Lgr5 in the progression into adenocarcinomas. We detected expression of the Lgr4/Lgr5 ligands Rspo1 and Rspo3 in KP LUAD; these ligands localized predominantly to endothelial cells in the tumours (Extended Data  Fig. 9a, b) . Analogously, endothelial cells expressing R-spondin form a part of the niche for liver stem cells Fig. 9c-e) . In situ hybridization (ISH) showed that expression of these three Wnt ligands in KP LUAD was found in regions with Wnt pathway activation (Fig. 3e) . Increased levels of WNT5A, WNT3, WNT5B and WNT10A in subpopulations of patients and, in particular, WNT7B were observed in human LUAD when compared to normal lung in the TCGA dataset (Extended Data Fig. 9f and Supplementary Table 3) . We detected robust expression of 8 out of the 10 Fzd receptors and their Lrp5 and Lrp6 co-receptors in sorted KP LUAD cells (Extended Data Fig. 9g) . Expression of Fzd1, Fzd4 and Fzd6 was increased in KP lung adenocarcinomas when compared to adenomas (Extended Data Fig. 9h ). Of note, each of these receptors can be engaged by at least one of the three Wnt ligands identified in the current study 24 . We next explored inhibition of ligand-dependent Wnt signalling as a potential therapeutic strategy in LUAD. Treatment with LGK974 suppressed Wnt target genes, inhibited tumour growth, proliferation and prolonged survival of mice with advanced autochthonous KP LUAD tumours (Fig. 4a-d and Extended Data Fig. 10a, b) . Furthermore, treatment of tumour donor mice with LGK974 markedly suppressed the tumour-forming ability of transplanted cells and reduced numbers of proliferative tumours in recipient mice ( Fig. 4e and Extended Data Fig. 10c-e) , suggesting that inhibiting Wnt can disrupt stem-like cells in LUAD (Fig. 4f) .
Our results indicate that a subset of Kras and p53 mutant LUAD cells acts as a Wnt-producing niche for another cancer cell subpopulation that responds to the Wnt signal and has robust proliferative potential (Fig. 4g) . Inhibiting porcupine disrupts Wnt secretion and activity in the niche, suppressing stem cell function in tumours, which ultimately translates into therapeutic benefit (Fig. 4f) . Inhibitors of Wnt signalling or the R-spondin-Lgr5 axis have also shown efficacy in patient-derived xenograft models of LUAD 25, 26 . We identified specific components of the Wnt-frizzled and R-spondin-Lgr5 signalling pathways that may serve as entry points for therapeutic approaches aimed at disrupting the interactions between niche cells and stem-like cells in LUAD (Fig. 4g) .
In this study, we observed the emergence of porcupine + niche cells and Lgr5
+ stem-like cells as KP lung adenomas progress to adenocarcinomas. This transition is also associated with amplification of the mutant Kras G12D locus and consequent increase in mitogenactivated protein kinase activity, as well as upregulation of tissue , suggesting that lung adenocarcinomas may be co-opting a latent tissue regenerative program upon progression. Our results indicate that Wnt pathway activity in a subset of cancer cells is essential for the maintenance of proliferative potential in LUAD, which presents a therapeutic opportunity for the treatment of lung adenocarcinoma and other epithelial cancers.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. , 1 × 10 8 PFU of AdCMV-FlpO (Iowa) or 15-50,000 transforming units of lentiviral Cre, as previously described 38, 39 , in mice that were between 8-12 weeks of age. Approximately equal numbers of male and female mice were included in all experimental groups in all mouse experiments. Mice bearing lung tumours were treated with 10 mg per kg per day of LGK974 (ref. 20) resuspended in 0.5% carboxymethylcellulose (Sigma-Aldrich) and 0.5% Tween 80 (Sigma-Aldrich) or vehicle (0.5% carboxymethylcellulose and 0.5% Tween 80 only). Weights of mice were followed weekly. The growth of autochthonous Kras 
;Rosa26
Luciferase/+ lung tumours was followed longitudinally by bioluminescence imaging, as previously described 34 . In brief, mice were anaesthetized by isoflurane inhalation, administered 100 mg kg −1 d-luciferin (Perkin Elmer) by intraperitoneal injection and imaged after 10 min, using the IVIS imaging system (Perkin Elmer). Such longitudinal imaging experiments were repeated three times and representative data from one such experiment is shown in Fig. 4a . Survival experiments were repeated three times and representative data from one such experiment is shown in Fig. 4b . For survival experiments, mice were randomized based on their tumour burden as assessed by μ CT. Mice were assigned a tumour burden score ranging from 0 (no tumours) to 10 (lungs completely full of tumours), and experimental groups were formed such that each group had approximately equal average tumour burdens. Mice with tumour burden scores under 3 were excluded from the study. The health of the mice in all experiments was monitored daily by the investigators and/or veterinary staff at the Department of Comparative Medicine at Massachusetts Institute of Technology. Mice with a body condition score under 2 were humanely euthanized. Animal studies were approved by the Massachusetts Institute of Technology (MIT) Committee for Animal Care (institutional animal welfare assurance no. A-3125-01). The maximal tumour dimensions permitted by the MIT Committee for Animal Care were 2 cm across the largest tumour diameter and this limit was not reached in any of the experiments. 
Isolation of primary mouse lung adenocarcinoma cells. Mice bearing

GFP-CreER/+
) LUAD tumours were euthanized 12-26 weeks after tumour induction and perfused with S-MEM (Gibco) through the right ventricle of the heart. Dissected lungs with tumours were dissociated in protease and DNase solution of the Lung Dissociation kit (Miltenyi Biotech) followed by mechanical dissociation using MACS C columns (Miltenyi Biotech) according to the manufacturer's instructions. The dissociated cells were filtered using a 100-μ m strainer and red blood cells were lysed using ACK (Thermo Scientific), followed by staining with APC-conjugated CD31 (Biolegend, 102510), CD45 (BD, 559864), CD11b (eBioscience, 17-0112-82) and TER119 (BD, 557909) antibodies and dead cells with DAPI (Sigma-Aldrich). The same approach using the Tumour Dissociation kit (Miltenyi Biotech) was used to isolate KPT;Lgr5 
/GFP
− (Lgr5 − cancer cell fraction) populations were sorted. Sorted cells were placed in 3D organotypic culture, transplanted intratracheally into NOD/SCID-γ (NSG) recipient mice, or subcutaneously into athymic nu/nu mice immediately after sorting (see below). Transplantation of cancer cells into recipient mice. For intratracheal transplantation, 8-10-weeks-old immunodeficient NSG mice were anaesthetized, intubated as previously described 38 , and allowed to inhale 15-50,000 sorted primary KP LUAD cancer cells resuspended in 30 μ l of S-MEM (Gibco). For subcutaneous transplantation, 50-500,000 sorted primary KP LUAD cells, KP LUAD cell lines or single-cell clones derived from a KP;Lgr5 GFP-CreER/+ LUAD cell line were resuspended in 50% Matrigel/50% S-MEM and injected subcutaneously into both flanks of athymic nu/nu mice in a volume of 100 μ l. Mice with transplant tumours were injected intraperitoneally with 1 mg of 5-ethynyl-2-deoxyuridine (EdU, Setareh Biotech) 4 h before euthanasia to label proliferating cells. EdU was detected in cryosections using the Click-iT EdU Alexa Fluor 488 Imaging kit (Thermo Scientific) according to the manufacturer's protocol. Lgr5
+ cells in close proximity to porcupine were detected by GFP and porcupine immunofluorescence. All GFP + cells were analysed as being immediately adjacent to at least one porcupine + cell, as double-positive for both GFP and porcupine, or as neither of the above (Fig. 3a) . All transplantation experiments were reproduced three times.
Low-density 3D organotypic cell culture. 150-1,000 primary mouse KP LUAD cells, cells from established KP LUAD cell lines, or primary mouse PDAC cells were mixed in 50% Matrigel (BD) and 50% advanced DMEM/F12 (Gibco) and plated on 10 μ l of Matrigel. The gel was allowed to solidify at 37 C, followed by addition of advanced DMEM/F12 (Thermo Scientific) supplemented with gentamicin (Thermo Scientific), penicillin-streptomycin (VWR), 10 mm HEPES (Thermo Scientific) and 2% heat-inactivated fetal bovine serum. For Wnt pathway manipulation, cultures were incubated with 1 μ g ml −1 recombinant mouse (rm)R-spondin 1 (Sino Biological), 100 ng ml −1 rmWnt3a (R&D Sytstems), 500 ng ml −1 or 1 μ g ml
rmDKK1 (R&D Systems) or 100 nM LGK974 (Medchem Express) for 6-14 days. Medium was changed every two days. At the end of the experiment, proliferating cells were labelled with 10 μ M EdU for 4 h, followed by paraformaldehyde fixation and fluorescent labelling of proliferating cells using the Click-iT EdU Alexa Fluor 488 Imaging kit (Thermo Scientific), according to the manufacturer's protocol, in whole-mount preparations of tumour spheroids. Proliferating spheroids were quantified using a Nikon Eclipse 80i microscope: a spheroid was classified as a cluster of at least 10 cells, and a proliferating spheroid contained at least one EdU positive nucleus (proliferating cells were not observed in clusters of cells smaller than 10 cells). At least four replicate wells per condition were quantified in each experiment. Images were acquired using a Nikon A1R confocal microscope. Stimulation and inhibitor experiments were reproduced at least 10 times for each experimental condition. Cell lines. Multiple cell lines were established from the mouse LUAD and PDAC KP GEMMs over the course of the study. The cell lines have not been authenticated.
The cell lines were routinely tested for mycoplasma and found to be negative. At the time of conducting the experiments, no cell lines used were found to be listed in the ICLAC database of misidentified cell lines.
Immunohistochemistry. Tissues or tumour organoids were fixed in 10% formalin overnight and embedded in paraffin. Immunohistochemistry (IHC) was performed on a Thermo Autostainer 360 with or without haematoxylin counterstaining using antibodies against β -catenin (BD, 610153), Ki67 (Vector Labs, VP-RM04), glutamine synthetase (BD, 610517), or porcupine (Abcam, ab105543). Lungs from at least three tumour-bearing mice were analysed for each antibody. Livers and small intestines collected from three normal, healthy mice were used for β -catenin, glutamine synthetase and porcupine IHC. 65 human LUAD tumours samples in two separate tissue microarrays were analysed by IHC for β -catenin and porcupine. 5 human colorectal adenocarcinoma samples were stained with porcupine antibodies. All human tissue material was obtained commercially from Janssen Pharmaceuticals. Tissue immunofluorescence. Mice were anaesthetized and perfused through the right cardiac ventricle with 1% paraformaldehyde. Lungs with tumours were dissected, immersed in 4% PFA overnight and frozen in OCT medium (Sakura Finetek). 7 μ m sections were stained with antibodies to EpCAM (eBioscience, 17-5791-82), β -catenin (BD, 610153), GFP (Cell Signaling Technologies, 2956S; or Aves Labs, GFP-1020), CD11b (eBioscience, 17-0112-82) or porcupine (Abcam, ab105543). Lungs from at least three tumour-bearing mice were analysed for each antibody. Quantification of cell proliferation in tumours. Digitally scanned images of Ki67-stained slides were created with the Aperio ScanScope AT2 at 20× magnification. Aperio's WebScope software was used to assess Ki67 + density per tumour area. A built-in IHC nuclear image analysis algorithm was used to classify cells on the basis of the intensity of the nuclear Ki67 stain. Nuclei were classified from 0 to 3+ ; only nuclei with moderate nuclear staining (2+ ) or intense nuclear staining (3+ ) were considered Ki67 + . Tumour regions were outlined on WebScope before running the IHC nuclear image analysis algorithm such that the number of 2+ and 3+ cells was normalized to tumour area. Quantitative PCR (qPCR). Total RNA was isolated from tumours or cells using the RNeasy plus kit (Qiagen) according to the manufacturer's instructions. cDNA was synthesized from 1 μ g of RNA using the SuperScript VILO cDNA synthesis kit (Thermo Scientific). qPCR was performed in triplicates with 2 μ l of diluted cDNA (1:10) using PerfeCTa SYBR Green FastMix (Thermo Scientific) on a BioRad iCycler RT-PCR detection system. Expression was normalized to Actb or Gapdh. All oligonucleotides used in this study are listed in Supplementary Table 4 . All qPCR experiments were reproduced using at least three biological replicates.
Alternatively, a Mouse WNT Signalling Pathway RT 2 Profiler PCR Array (Qiagen) was used according to the manufacturer's instructions. Raw expression values were thresholded to remove genes that were not detected or had low expression (maximum C t value set to 33; 0 values set to 33). Array position to gene-name mapping details were retrieved from the manufacturer's website (www. pcrdataanalysis.sabiosciences.com). Expression values for all genes per array were normalized to the expression of the housekeeping gene Gusb. Three replicates of stroma samples and three replicates of tumour samples were compared to calculate log 2 fold change and differential expression significance values (two-sided t-test) . Lentiviral shRNA-mediated gene silencing. shRNAs were cloned into lentiviral pLKO.1 vectors (Addgene, 10878) or into pTRIPZ (Dharmacon) vectors and Letter reSeArCH lentivirus was produced as previously described 40 . KP mouse LUAD cell lines were infected with the lentiviral vectors, followed by puromycin selection and, in the case of cells infected with the TRIPZ virus, incubation in 1 μ g ml −1 doxycycline for four days and RNA extraction for testing target knockdown (Extended Data Fig. 2a and not shown). For combined Lgr4 and Lgr5 silencing experiments, cell lines expressing pLKO.1 driving Lgr4 or Lgr5 shRNAs were generated by puromycin selection, followed by infection with TRIPZ vectors driving miR30-based Lgr4 or Lgr5 shRNAs and turboRFP under the control of a TET-responsive promoter. Cells were incubated in 1 μ g ml −1 doxycycline for two days and red fluorescent cells were sorted to generate pure cell lines expressing combinations of Lgr4 and Lgr5 shRNAs. All shRNA experiments were reproduced using at least three independent cell lines. TOPFLASH assay. 10,000 of KP LUAD cells were plated in 100 μ l of medium containing 10% FBS per well of a white-walled 96-well plate (Perkin Elmer). After 24 h, mouse KP LUAD cells were transfected using Attractene transfection reagent (Qiagen) according to the manufacturer's instructions with 150 ng of the TOPFLASH Firefly (M50) reporter 41 (Addgene, 12456) and 20 ng of pRL-SV40P Renilla (Addgene, 27163) constructs. In initial experiments, the Wnt-insensitive FOPFLASH (negative control) Firefly (M51) reporter 41 (Addgene, 12457) was used to rule out signal background (not shown). Cells were stimulated for 16 h with recombinant Rspo1 (1 μ g ml −1
, Sino Biological), recombinant Wnt3a (100 ng ml −1 , R&D Systems) or their combination (RW) in advanced DMEM/ F12 (Gibco), with supplements listed above. After stimulation, Firefly and Renilla signals were detected using Dual-Glo luciferase detection reagents (Promega) according to the manufacturer's instructions. A Tecan Infiniti 200 Pro plate reader and automated injector system was used to detect luminescence. To control for transfection efficiency, Firefly luciferase levels were normalized to Renilla luciferase levels to generate a measurement of relative luciferase units. Experimental data are presented as mean ± s.d. from three independent wells. All TOPFLASH experiments were reproduced using at least three independent cell lines. Application of the synergistic activation mediator system to overexpress components of the R-spondin-Lgr5 axis. Catalytically dead Cas9 (dCas9)-based systems have recently emerged as powerful tools for transcriptionally activating endogenous genes 42 . Notably, these systems allow for overexpression of genes in their endogenous genomic context. To overexpress Rspo2, Rspo3 or Lgr5 in Kras G12D/+
;Trp53
Δ/Δ LUAD cell lines, we used the SAM system, which is a three-component system based on: (1) the fusion of dCas9 to the transcriptional activator VP64 (a tandem repeat of four DALDDFDLDML sequences from Herpes simplex viral protein 16, VP16); (2) a modified gRNA scaffold containing two MS2 RNA aptamers; and (3) the MS2-p65-HSF1 tripartite synthetic transcriptional activator 21 . In this system, sgRNA-dependent recruitment of dCas9-VP64 and MS2-P65-HSF1 to the endogenous Rspo2, Rspo3 or Lgr5 loci results in potent transcriptional activation (Extended Data Fig. 1i-l) .
Non-clonal Kras G12D/+ ;Trp53 Δ/Δ ;Rosa26 tdTomato/+ or Kras G12D/+ ;Trp53 Δ/Δ ; Lgr5 GFP-CreER/+ LUAD cells stably expressing dCas9-VP64-blast (Addgene, 61425) and MS2-P65-HSF1-hygro (Addgene, 61426) were generated using sequential lentiviral transduction and selection with blasticidin and hygromycin, respectively. To overexpress Rspo2 or Rspo3 we designed four independent sgRNA sequences targeting the Rspo2 or Rspo3 transcription start site; sgRNAs targeting the upstream region of the Lgr5 gene were provided by L. Gilbert, M. Horlbeck and J. Weissman 43 . The sgRNAs were cloned into a lentiviral vector (Lenti-sgRNA-MS2-zeocin; Addgene, 61427) followed by transduction and zeocin selection of the aforementioned cell lines to generate Kras 
;Lgr5
GFP-CreER/+ LUAD cell lines stably expressing all three components. These experiments were reproduced using three independent cell lines. Cloning of lentiviral vectors. The 7TCF::luciferase-PGK::Cre, 7TCF::GFP-PGKCre and U6::sgRNA-EFS::Cre (pUSEC) lentivirus vectors were generated by Gibson assembly 44, 45 . In brief, a 1.8-kb part corresponding to 7TCF::luciferase or a 1.2-kb part corresponding to 7TCF::GFP were amplified from 7TFP (Addgene, 24308, ref. 46) or 7TGP (Addgene, 24305, ref. 46 ) respectively, and fused with a 0.5-kb PGK promoter part, a 1.0-kb Cre cDNA part and the PmeI and BsrGI linearized LV1-5 (Addgene, 68411) part 44 . U6::sgRNA-EFS::Cre was generated by amplifying a 2.2-kb part corresponding to the U6-filler-chimeric gRNA backbone from pSECC (Addgene, 60820), and fused with a 0.25-kb EFS promoter part, a 1.0-kb Cre cDNA part and the PmeI and BsrGI linearized LV1-5 (Addgene, 68411) part 44 . Lentivirus was produced in 293FS* cells, as previously described 38 . Experiments using 7TCF::luciferase-PGK::Cre (Fig. 2a) were performed twice (n = 15 mice in total) and experiments using 7TCF::GFP-PGK-Cre (Fig. 2b) three times (n = 19 mice in total).
For generation of lentiviruses containing sgRNAs, three sgRNAs per gene targeting Porcn, Lgr4 or Lgr5 were designed using CRISPR Design 47 , cloned into pSpCas9(BB)-2A-GFP (pX458, Addgene, 48138) as previously described 48 , transfected into KP cells 49 , and screened for efficiency by western blotting for porcupine protein or by massively parallel sequencing of the regions in Lgr4 or Lgr5 targeted by the respective sgRNAs (data not shown). The most efficient Porcn sgRNA was cloned into pSECC as previously described 49 . The most efficient Lgr4 and Lgr5 sgRNAs were cloned into the pUSEC vector together with a synthetic mouse/human U6 promoter (sU6), as previously described 50 , to generate U6::sgLgr4-sU6::Lgr5-EFS::Cre (pU2SEC).
Measurement of Wnt signalling pathway activity in tumours in vivo.
A KPT LUAD cell line was transduced with 7TCF::luciferase-PGK::Puro (7TFP) lentiviruses 46 , selected for puromycin resistance, and transplanted subcutaneously into flanks of immunodeficient athymic nu/nu mice. Three weeks after transplantation, tumour burden was measured by registering tdTomato fluorescence using an IVIS imaging system (Perkin Elmer), followed by administration of 100 mg kg −1 d-Luciferin (Perkin Elmer) and detection of the luciferase signal (7TCF promoter activity). The luciferase signal was normalized to the tdTomato signal (Wnt pathway activity/total tumour burden). Quantification of Wnt pathway activity was performed every 24 h for a week in mice treated with 10 mg per kg per day of LGK974 or vehicle. The maximal tumour dimensions permitted by the MIT IACUC were 2 cm across the largest tumour diameter and this limit was not reached in these experiments. This experiment was performed twice. Single-molecule mRNA in situ hybridization. Single-molecule in situ hybridization was performed on formalin-fixed paraffin-embedded tissues using the Advanced Cell Diagnostics RNAscope 2. ) or corn-oil vehicle control. Tumours were collected at 2 days or 14 days after tamoxifen administration and prepared for cryosectioning. Three sections 500 μ m apart were prepared from each tumour and imaged under a fluorescence microscope. The number of GFP + cells per section was quantified in nine tumours per time point. μCT data acquisition and analysis. An eXplore CT 120 microcomputed tomography (μ CT) system (Northridge Tri-Modality Imaging Inc.) was used for in vivo imaging. Mice were imaged under anaesthesia (induced at 3% isoflurane in oxygen, maintained at between 2-2.5% during imaging) in groups of 4 in a custom mouse holder. Scanner settings were as follows: 720 views, 360° rotation, 70 kVp, 50 mA, 32 ms integration time with 2 × 2 detector pixel binning (isotropic nominal resolution of 50 μ m). Data were reconstructed using the Parallax Innovations GPU accelerated reconstruction engine for the eXplore CT120.
Tissue density values (in Hounsfield Units (HU)) for normal, air-filled lung parenchyma were determined by eye using MicroView software (Parallax Innovations). For the scanning conditions in this study a range of − 550 to − 300 HU was determined to represent the range of normal lung parenchyma values. A custom analysis script was created using MATLAB (MathWorks) to identify a region of interest (ROI) including the soft tissue of the mouse thorax. Within this region the volume of tissue within the 'healthy' density range was measured. Within this same volume minimum intensity projections (MinP) were created, both to confirm the accuracy of the ROI and to qualitatively assess lung pathology. For data visualization, the change in healthy lung volume was inverted to represent the change in tumour volume (Extended Data Fig. 10b ). One experiment involving 9 mice treated with LGK974 and 11 mice treated with vehicle control was carried out to track changes in tumour volume (Extended Data Fig. 10b) . Human clinical data analyses. RNA-seq gene expression profiles of primary tumours and relevant clinical data of 488 patients with lung adenocarcinoma were obtained from The Cancer Genome Atlas (TCGA LUAD; http://cancergenome. nih.gov/). The previously published Wnt signalling geneset 22 (24 genes upregulated after stimulation with recombinant human WNT3A) was obtained from the Molecular Signatures Database (MSigDB) 51 and used to score individual patient expression profiles using ssGSEA 52, 53 . Patients were stratified according to their correlation score, into top (n = 115) and bottom (n = 114) 20th percentile sets. Kaplan-Meier survival analysis was conducted between these sets of patients and the log-rank test was used to assess significance. Subsequently, the KaplanMeier survival analysis methodology was extended to assess significant survival differences across 35 TCGA cancer types using a similar strategy.
Additionally, the Cox proportional hazards regression model was used to analyse the prognostic value of the published geneset 22 across all patients within the TCGA LUAD cohort, in the context of additional clinical covariates. All univariate and multivariable analyses were conducted within a five-year survival timeframe. The following patient and tumour-stage clinical characteristics were used: signature (signature from ref. 22 strong versus weak correlation); gender Letter reSeArCH (male or female); age (years, continuous); smoking history (reformed > 15 years versus non-smoker, reformed < 15 years versus non-smoker, current smoker versus non-smoker); mutational load (derived as the number of non-silent mutations per 30 Mb of coding sequence, continuous); Union for International Cancer Control (UICC) TNM Stage specification (stage III/IV versus I/II); UICC T score specification (T2 versus T1, T3/T4 versus T1); UICC N score specification (N1/N2 versus N0). Hazard ratio proportionality assumptions for the Cox regression model were validated by testing for all interactions simultaneously (P = 0.703). Interaction between the signature of ref. 22 and TNM stage, T score and N score (significant covariates in the model) were tested using a likelihood ratio test to contrast a model consisting of both covariates with another model consisting of both covariates plus an interaction term. No statistically significant difference was found between the two models (TNM, P = 0.8751; T score, P = 0.8204; N score: P = 0.8625; likelihood ratio test). To test for statistically significant differences between the previously published 22 signature correlation scores across TCGA LUAD grade levels (T scores), the Kurskal-Wallis test was used to assess overall significance and the Mann-Whitney-Wilcoxon test was used to assess pairwise differences. All statistical analyses were conducted in R (http://www.R-project. org) and all survival analyses and were conducted using the survival package in R.
Finally, we analysed the expression of Wnt pathway genes present in the Mouse WNT Signalling Pathway RT 2 . Profiler PCR Array (Qiagen) in the human TCGA LUAD data (Supplementary Table 3 ). Expression levels between 57 LUAD tumour samples and corresponding matched normal samples were analysed using empirical cumulative distribution function plots. Significance of different expression levels was assessed using the Kolmogorov-Smirnov test. For a more comprehensive analysis covering human orthologues of all WNT pathway genes tested on the mouse qPCR array, pairwise differential expression analysis (tumour versus normal, n = 57 each) was performed using EBSeq version 1.4.0 (ref. 54) . Massively parallel sequencing. CRISPR-Cas9-induced mutations were detected as before 59 . Briefly, genomic regions containing the sgPorcn, sgLgr4 or sgLgr5 target sequences were amplified using Herculase II Fusion DNA polymerase and gel purified (primer sequences are shown in Supplementary Table 4) . Sequencing libraries were prepared from 50 ng of PCR product using the Nextera DNA Sample Preparation kit (Illumina) according to the manufacturer's instructions and sequenced on Illumina MiSeq sequencers to generate 150-bp, paired-end reads. Bioinformatic analysis of target loci. CRISPR-Cas9-mutated loci were computationally analysed as before 59 . Briefly, illumina MiSeq reads (150 bp paired-end) were trimmed to 120 bp after reviewing base quality profiles, in order to remove lower quality 3′ ends. Traces of Nextera adapters were clipped using the FASTX toolkit (Hannon Laboratory, CSHL) and pairs with each read greater than 15 bp in length were retained. Additionally, read pairs where either read had 50% or more bases below a base quality threshold of Q30 (Sanger) were removed from subsequent analyses. The reference sequence of the target locus was supplemented with 10 bp genomic flanks and was indexed using an enhanced suffix array 55 . Read ends were anchored in the reference sequence using 10 bp terminal segments for a suffix array index lookup to search for exact matches. A sliding window of unit step size and a maximal soft-clip limit of 10 bp were used to search for possible anchors at either end of each read. For each read, optimal Smith-Waterman dynamic programming alignment 56 was performed between the reduced state space of the read sequence and the corresponding reference sequence spanning the maximally distanced anchor locations. Scoring parameters were selected to allow sensitive detection of short and long insertions and deletions while allowing for up to four mismatches and the highest scoring alignment was selected. Read pairs with both reads aligned in the proper orientation were processed to summarize the number of wild-type reads and the location and size of each insertion and deletion event. Overlapping reads within pairs were both required to support the event if they overlapped across the event location. Additionally, mutation events and wild-type reads were summarized within the extents of the sgRNA sequence and PAM site by considering read alignments that had a minimum of 20 bp overlap with this region. Mutation calls were translated to genomic coordinates and subsequently annotated using Annovar 57 . The alignment and post-processing code was implemented in C+ + along with library functions from SeqAn 58 and SSW 59 and utility functions in Perl and R (http://www.R-project.org). Mutation calls were subjected to manual review using the Integrated Genomics Viewer (IGV) 60 . ), Wnt3a (100 ng ml −1 ) or both (1 μ g ml −1 Rspo1 and 100 ng ml −1 Wnt3a), or Wnt pathway inhibition with LGK974 (100 nM) or DKK1 (500 ng ml −1 ) for seven days (starting at seven days after plating). EdU labelling was performed 16 h before analysis of proliferating cells by flow cytometry. n = 6 wells per condition. b, Percentage of spheroids proliferating in low-density 3D cultures of primary mouse KPT LUAD cells 14 days after plating. n = 8 wells per condition. Representative data from eight replicate experiments; TT5678 and TT5861 identify donor mice. c, qPCR of Porcn transcripts in sublines of a KP LUAD cell line expressing shRNAs targeting Porcn (shPorcn) or control shRNA (shLuc). Quantification of 3D tumour spheroids containing EdU + cells of KP LUAD cells expressing the indicated shRNAs in response to 100 ng ml −1
Statistics
Wnt3a or control at six days after plating. Representative data of n = 3 technical replicates, the experiment was performed with three independent cell lines. e, Quantitative real-time PCR (qRT-PCR) analysis of Axin2 and Lgr5 transcripts in 3D cultures of primary KP LUAD cells following Wnt pathway stimulation with Rspo1 (1 μ g ml −1 ), Wnt3a (100 ng ml −1 ) or both (1 μ g ml −1 Rspo1 and 100 ng ml −1 Wnt3a), or Wnt pathway inhibition with LGK974 (100 nM) or DKK1 (1 μ g ml −1 ) for six days (starting at 10 days after plating). Representative data of n = 3 technical replicates. The experiment was carried out three times, each time with cells isolated from a different tumour-bearing mouse.
f, Quantification of tumour spheroids containing EdU + cells per 100 primary KPT LUAD cells 14 days after plating. Combined treatment (1 μ g ml −1 Rspo1 and 100 ng ml −1 Wnt3a); LGK974 (100 nM). n = 8 wells per condition. g, Recipient mouse lungs eight weeks after orthotopic transplantation of 30,000 primary tdTomato + (red) mouse KP LUAD cells. Arrowheads indicate tdTomato + tumours. Recipient mice were treated with 10 mg per kg per day LGK974 or vehicle for eight weeks, starting from the day of transplantation. Scale bar, 2 mm. The experiment was performed three times, each time with cells isolated from a different (donor) tumour-bearing mouse. h, Wnt-pathway activity measured by detection of firefly luciferase driven by a Wnt-sensitive 7TCF promoter (Topflash assay) in mouse KP LUAD cells stimulated for 24 h with the indicated growth factors. n = 3 technical replicates per condition. Representative data from experiments that were performed with four different cell lines. i-k, qPCR analysis of Rspo2 (i), Rspo3 (j) or Lgr5 (k) transcripts in two independent mouse KP LUAD cell lines (TT5734 and TT5764) expressing SAM components 21 driving expression of the indicated genes. l, Flow cytometry analysis of GFP fluorescence in a KP LUAD cell line containing the Lgr5 GFP-CreER reporter 36 expressing vector control (top) or an sgRNA targeting the transcription start site of Lgr5 (bottom). m, n, qRT-PCR analysis of the Wnt target genes Axin2 (m) and Lgr5 (n) in 3D cultures of sublines of a KP LUAD cell line (TT5764) expressing the CRISPR-activator system driving expression of Rspo2 (Rspo2-a), Rspo3 (Rspo3-a) or Lgr5 (Lgr5-a). Data are mean ± s.d.; * P < 0.05; * * P < 0.01; * * * P < 0.001; * * * * P < 0.0001; n.s., not significant; two-way ANOVA (a, b, d, h, m, n) or Student's two-sided t-test (c, e, f, i-k).
